Crocs Inc. (CROX) Jumps 7.12% on January 20

Equities Staff |

Crocs Inc. (CROX) was among the biggest gainers on the Russell 2000 for Wednesday January 20 as the stock popped 7.12% to $9.03, representing a gain of $0.6 per share. Some 815,410 shares traded hands on 5,346 trades, compared with an average daily volume of 1.18 million shares out of a total float of 73.66 million. The stock opened at $8.32 and traded with an intraday range of $9.03 to $8.29.

After today's gains, Crocs Inc. reached a market cap of $665.14 million. Crocs Inc. has had a trading range between $16.05 and $8.15 over the last year, and it had a 50-day SMA of $10.20 and a 200-day SMA of $12.92.

Crocs Inc and its subsidiaries are engaged in the design, development, manufacturing, marketing and distribution of consumer products, which includes footwear and accessories for men, women and children. It sells it products through retail chains.

Crocs Inc. is based out of Niwot, CO and has some 4,900 employees. Its CEO is Gregg S. Ribatt.

For a complete fundamental analysis analysis of Crocs Inc., check out’s Stock Valuation Analysis report for CROX. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets


D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…


Lyft matches drivers using their own personal vehicles with passengers who request rides through the smartphone app, and the passengers pay automatically through the app. When using Lyft, passengers have…